Human Genome Epidemiology Literature Finder
Records 1 - 22 (of 22 Records) |
Query Trace: Neoplasms and NOV[original query] |
---|
Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis. International journal of cancer. Journal international du cancer 2011 May 128 (10): 2326-34. Gannon Philippe O, Medelci Sanae, Le Page Cécile, Beaulieu Martin, Provencher Diane M, Mes-Masson Anne-Marie, Santos Manuela |
Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development. BMC medical genetics 2011 12 (1): 156. Brisbin Abra G, Asmann Yan W, Song Honglin, Tsai Ya-Yu, Aakre Jeremiah A, Yang Ping, Jenkins Robert B, Pharoah Paul, Schumacher Fredrick, Conti David V, Duggan David J, Jenkins Mark, Hopper John, Gallinger Steven, Newcomb Polly, Casey Graham, Sellers Thomas A, Fridley Brooke |
GSTP1, ERCC1 and ERCC2 polymorphisms, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in colorectal cancer in Chinese population. Asian Pacific journal of cancer prevention : APJCP 2012 13 (7): 3465-9. Li Hui-Yan, Ge Xin, Huang Guang-Ming, Li Kai-Yu, Zhao Jing-Quan, Yu Xi-Miao, Bi Wen-Si, Wang Yu-L |
The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2012 13 (4): 1355-60. Liu Chuan, Wang Ying, Wang Qing-Shui, Wang Ya-J |
Prognostic significance of GSTP1, XRCC1 and XRCC3 polymorphisms in non-small cell lung cancer patients. Asian Pacific journal of cancer prevention : APJCP 2012 13 (9): 9. Ke HG, Li J, Shen Y, You QS, Yan Y, Dong HX, Liu JH, Shen ZY |
Association between HIF1A P582S and A588T polymorphisms and the risk of urinary cancers: a meta-analysis. PloS one 2013 8 (5): e63445. Li Dawei, Liu Jikai, Zhang Wenhua, Ren Juchao, Yan Lei, Liu Hainan, Xu Zhongh |
Common variations of DNA repair genes are associated with response to platinum-based chemotherapy in NSCLCs. Asian Pacific journal of cancer prevention : APJCP 2013 14 (1): 145-8. Li Xian-Dong, Han Ji-Chang, Zhang Yi-Jie, Li Hong-Bing, Wu Xue-Y |
Association between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population. Asian Pacific journal of cancer prevention : APJCP 2012 13 (11): 5721-4. Gan Yi, Li Xiao-Rong, Chen Dao-Jin, Wu Jun-H |
Angiotensin-converting enzyme insertion/deletion polymorphism and gastric cancer: a systematic review and meta-analysis. International journal of clinical and experimental medicine 2015 8 (4): 5788-93. Gan Lu, Liu Xinyang, Wu Zhenhua, Huang Mingzu, Zhang Xiaowei, Guo Weiji |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis. Lung cancer (Amsterdam, Netherlands) 2016 Apr 94 46-53. Chen Li-Yang, Molina-Vila Miguel A, Ruan Sheng-Yuan, Su Kang-Yi, Liao Wei-Yu, Yu Kai-Lun, Ho Chao-Chi, Shih Jin-Yuan, Yu Chong-Jen, Yang James Chih-Hsin, Rosell Rafael, Yang Pan-Ch |
Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies. Medicine 2016 Oct 95 (43): e5156. Zhuo Xianlu, Song Jue, Liao Jian, Zhou Wei, Ye Huiping, Li Qi, Xiang Zhaolan, Zhang Xueyu |
WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma. Urologic oncology 2017 Dec . Lee Hsiang-Lin, Chiou Hui-Ling, Wang Shian-Shiang, Hung Sheng-Chun, Chou Ming-Chih, Yang Shun-Fa, Hsieh Ming-Ju, Chou Ying-E |
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet. Oncology 2018 Jun . Clarke Noel, Wiechno Pawel, Alekseev Boris, Sala Nuria, Jones Robert, Kocak Ivo, Chiuri Vincenzo Emanuele, Jassem Jacek, Fléchon Aude, Redfern Charles, Goessl Carsten, Burgents Joseph, Kozarski Robert, Hodgson Darren, Learoyd Maria, Saad Fr |
Breast and ovarian cancer penetrance of BRCA1/2 mutations among Hong Kong women. Oncotarget 2018 May 9 (38): 25025-25033. Zhang LingJiao, Shin Vivian Y, Chai Xinglei, Zhang Alan, Chan Tsun L, Ma Edmond S, Rebbeck Timothy R, Chen Jinbo, Kwong A |
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet. Oncology 2019 8 20 (9): 1226-1238. Saura Cristina, Hlauschek Dominik, Oliveira Mafalda, Zardavas Dimitrios, Jallitsch-Halper Anita, de la Peña Lorena, Nuciforo Paolo, Ballestrero Alberto, Dubsky Peter, Lombard Janine M, Vuylsteke Peter, Castaneda Carlos A, Colleoni Marco, Santos Borges Giuliano, Ciruelos Eva, Fornier Monica, Boer Katalin, Bardia Aditya, Wilson Timothy R, Stout Thomas J, Hsu Jerry Y, Shi Yi, Piccart Martine, Gnant Michael, Baselga José, de Azambuja Evand |
Association of Matrix Metalloproteinase1-1607 1G>2G Polymorphism and Lung Cancer Risk: An Update by Meta-Analysis. Asian Pacific journal of cancer prevention : APJCP 2019 06 20 (6): 1841-1847. Ma Yue, Yang Xi, Xie Yu-Ping, Yi Cheng, Zhao Fen, Huang Yi |
No association between three polymorphisms (rs1800629, rs361525 and rs1799724) in the tumor necrosis factor-a gene and susceptibility to prostate cancer: a comprehensive meta-analysis. Hereditas 2020 Apr 157 (1): 11. Yin Lei, Yue Chuang, Jing Hongwei, Yu Hongyuan, Zuo Li, Liu T |
Relationship between Aurora-A V57I Polymorphism and the Risk of Cancer: A Meta-Analysis and Trial Sequential Analysis. Journal of Cancer 2020 4 11 (11): 3225-3234. Chen Guangyuan, Hu Cong, Song Yuxuan, Xiu Mengxi, Zhang Yiling, Lai Penghui, Li Yunyan, Liu Xiaoqiang, Huang Pe |
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial. The Lancet. Respiratory medicine 2021 8 10 (1): 72-82. Kawashima Yosuke, Fukuhara Tatsuro, Saito Haruhiro, Furuya Naoki, Watanabe Kana, Sugawara Shunichi, Iwasawa Shunichiro, Tsunezuka Yoshio, Yamaguchi Ou, Okada Morihito, Yoshimori Kozo, Nakachi Ichiro, Seike Masahiro, Azuma Koichi, Kurimoto Futoshi, Tsubata Yukari, Fujita Yuka, Nagashima Hiromi, Asai Gyo, Watanabe Satoshi, Miyazaki Masaki, Hagiwara Koichi, Nukiwa Toshihiro, Morita Satoshi, Kobayashi Kunihiko, Maemondo Mako |
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet. Oncology 2021 3 22 (5): 620-631. Poveda Andrés, Floquet Anne, Ledermann Jonathan A, Asher Rebecca, Penson Richard T, Oza Amit M, Korach Jacob, Huzarski Tomasz, Pignata Sandro, Friedlander Michael, Baldoni Alessandra, Park-Simon Tjoung-Won, Tamura Kenji, Sonke Gabe S, Lisyanskaya Alla, Kim Jae-Hoon, Filho Elias Abdo, Milenkova Tsveta, Lowe Elizabeth S, Rowe Phil, Vergote Ignace, Pujade-Lauraine Eric, |
Association of the interaction between mosaic chromosomal alterations and polygenic risk score with the risk of lung cancer: an array-based case-control association and prospective cohort study. The Lancet. Oncology 2022 10 23 (11): 1465-1474. Qin Na, Wang Cheng, Chen Congcong, Yang Liu, Liu Su, Xiang Jun, Xie Yuan, Liang Shuang, Zhou Jun, Xu Xianfeng, Zhao Xiaoyu, Zhu Meng, Jin Guangfu, Ma Hongxia, Dai Juncheng, Hu Zhibin, Shen Hongbi |
Multiple sclerosis and breast cancer risk: a meta-analysis of observational and Mendelian randomization studies. Frontiers in neuroinformatics 2023 5 17 1154916. Tian Fang, Zhihao Zhang, Huijie Zhou, Wanchun Wu, Liqun Z |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: